RNS Number : 9321G
Sulnox Group PLC
11 November 2025
 

 

 

 

11 November 2025 

 

Sulnox Group Plc 

(the "Company" or "Sulnox")

 

 

 (Aquis Stock Exchange: SNOX)

 

 

Sulnox at Aquis Showcase Investor Conference

 

 

Sulnox, the greentech company delivering lower fuel costs and reduced emissions, with zero capex, is pleased to announce that it will be presenting and exhibiting at the fourth Aquis Showcase conference on Wednesday 19th November 2025.

 

The event will be held at the Royal College of Surgeons, 38-43 Lincoln's Inn Fields, London, WC2A 3PE.  Sulnox's CEO, Ben Richardson, will be introducing the company to delegates and taking questions.

 

The presentation follows a record second quarter, with revenue reaching £679.3k, a 186% increase on Q2 2024, and continued recognition in the industry, having been named a finalist for AQSE Company of the Year for the second year running.

 

A copy of the presentation that will be made can be viewed on the Company's website at: https://sulnoxgroup.com/investors/   

 

For further information and tickets for the Aquis Showcase conference, please visit the event website at:

https://www.eventbrite.co.uk/e/aquis-showcase-tickets-1733700999359

 

 

ENDS

 

For further information please contact:

 

Sulnox Group plc

Alex Judd, Head of Marketing & Communications

[email protected]

 

Allenby Capital Limited

(AQSE Corporate Adviser)

Nick Harriss / John Depasquale

(Corporate Finance)

Amrit Nahal

(Equity Sales)

 

Tel: 020 3328 5656

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABMBFTMTTBBFA